SC-43 treatment decreased FN1 expression in M2 macrophages (Fig. 5B) suggesting another possibility, i.e., that SC-43 may contribute to mitigation of pulmonary fibrosis by inhibiting fibroblast recruitment. The gene discussed is FN1; the disease is pulmonary fibrosis.